The global live biotherapeutic products (LBP) and microbiome contract development and manufacturing organization (CDMO) market is experiencing rapid growth, driven by increasing research in microbiome-based therapies and rising demand for outsourcing pharmaceutical development. Live biotherapeutics are emerging as a promising approach for treating a wide range of diseases, including...